Evercore ISI Group Downgrades Exact Sciences to In-Line, Maintains Price Target to $105

Benzinga · 6d ago
Evercore ISI Group analyst Vijay Kumar downgrades Exact Sciences (NASDAQ:EXAS) from Outperform to In-Line and maintains the price target from $105 to $105.